Popular Articles

Clinical Studies Validate Cancer Gene Delivery Platform: Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers
Epeius Biotechnologies stuns the medical and scientific communities with a dramatic demonstration of single-agent efficacy with its lead product, Rexin-G, for metastatic cancer. The landmark article (accessible online as of June 16, 2009 in Molecular Therapy, the Official Journal of The American Society of Gene Therapy, documents the results of two related studies using Rexin-G, a tumor-targeted anti-cancer agent designed to seek-out and destroy metastatic cancers that have spread throughout the body, while sparing normal cells and healthy tissues and organs. Following the FDA"s designation of Rexin-G as an Orphan Drug for the treatment of soft tissue sarcoma and osteosarcoma in 2008, the results of these two independent studies represent a major step toward gaining Accelerated Approval of Rexin-G for osteosarcoma in the United States.

Prime Minister Pledges Action On Maternal Mortality, UK
Today, the Prime Minister, Gordon Brown, said he was determined to keep the issue of maternal mortality high on the agenda of the G8 summit in Italy next week.
News of the day
Research In Adolescent Addiction Supported By Early Stimulus Funding
A Brown University professor is among the first in the country to win a federal research grant funded by national economic stimulus efforts.
Mental Health

Weight Loss In Old Age May Signal Dementia

A new study shows that older people who are thinner or are losing weight quickly are at a higher risk of developing dementia, especially if they started out overweight or obese. The research is published in the May 19, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology. For the study, researchers followed for eight years 1,836 Japanese Americans in Washington state with an average age of 72. During that time, 129 people developed dementia. The research found that people with lower body mass index (BMI) scores at the beginning of the study were 79 percent more likely to develop dementia than those with higher BMI scores. In addition, those who lost weight over the study period at a faster rate were nearly three times more likely to develop dementia than those who lost weight more slowly over time. This result was more pronounced in those who were overweight or obese to start; those with a BMI of 23 or higher had an 82-percent reduced risk of developing the disease compared to those who were normal or underweight. The results were the same after testing for other health risk factors such as smoking, exercise and gender. "Our finding suggests that losing weight quickly in older age may be an early sign of dementia," said study author Tiffany Hughes, PhD, MPH, who is with the University of Pittsburgh School of Medicine but conducted the research while she was a doctoral student at the University of South Florida. "This doesn"t mean that being obese or overweight is healthy for the mind or body, but losing weight may be a sign of emerging brain disease." Hughes says other current research shows that, in contrast, a larger belly in midlife may be a risk factor for dementia. "Dementia has been shown to develop in the brain decades before any symptoms develop," Hughes said. "These findings likely reflect that process. In middle age, obesity may be a risk factor for dementia, while declining weight in late life may be considered one of the first changes from the disease that occurs before it actually affects a person"s memory." The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as multiple sclerosis, restless legs syndrome, Alzheimer"s disease, narcolepsy, and stroke. American Academy of Neurology (AAN)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):